AIM AND SCOPE
Journal of Cancer Research and Therapeutic Oncology (JCRTO) aims at rapid publication of high quality results in cancer research while maintaining rigorous peer-review process. All accepted papers will be appeared online immediately.
JCRTO encourages submission of manuscripts related to (but not limited to) cancer genetics, cancer cytology, cancer pathology, gynecologic cancer, ovarian cancer, clinical aspects of breast cancer, Lung cancer, cancer endocrinology , genitourinary cancer, colorectal cancer, bone cancer, prostate cancer.
The journal publishes original articles in the following areas:
• Benign Tumors
• Cancer Chemotherapy
• Pediatric Oncology
• Cancer prevention
• Molecular biology
• Recent developments in tumor therapy
• Radiation oncology
• Cancer image and interventional diagnosis and therapy
• Tumor markers
• Radiotherapy and biotherapy
• Veterinary and Comparative Oncology
• Clinical Trials in Oncology
• Cancer Nanotechnology
Publication of article types:
Original research articles: Describes original research within the scope of the journal.
Case reports: Reports of clinical presentations describing a diagnostic or therapeutic dilemma followed by evaluative studies
Editorial comments: Introduce current research and comment on major advances and developments in the field.
Methodology: Present a new experimental method, test or procedure. The methods described may be completely new or a better version of already existing one. The method should demonstrate all the possible tests and results.
Rapid communications: Short papers presenting highly significant and original material.
Review articles: To review the progression of a research in the field and make suggestions for future work includes authoritative, comprehensive, descriptions of any subject within the scope of Cancer research & Therapy journal.
Letters to the editor: Letter consisting of comments directly on publications of journal which are already published or introduces a specific issue of a general interest.
As Journal of Cancer Research and Therapeutic Oncology follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles through online and JCRTO will be kept up to date with latest advances in the field of cancer research. All published articles will be assigned with unique Digital Objective Identifier provided by Cross Ref.